Mycobiome

A mycobiome is a localized fungal community and the collective genetic material associated with it. In host biology, the word often refers to fungi living on or in the body without necessarily causing disease. The human mycobiome includes organisms found in the mouth, skin, intestine, vagina, and respiratory tract, although each site has a distinct composition.¹

Mycobiomes are usually smaller in biomass than bacterial communities, but their ecological effects can be disproportionate. Fungi alter nutrient availability, compete with other microbes, and interact with host tissues. The term is broader than a list of fungal species: it may encompass transient spores, metabolically active residents, dormant cells, and fungi associated with particles or surfaces.

Mycobiome research commonly combines cultivation with DNA-based surveys because neither approach detects the whole community alone. Fungal cultures reveal viable organisms and physiological traits, whereas metagenomics and targeted sequencing can detect organisms that are difficult to grow.²

The internal transcribed spacer, or ITS, region is a widely used fungal barcode, but reference databases and variable copy numbers can complicate identification. Results also depend on sampling depth, extraction methods, contamination controls, and whether the assay measures DNA from living cells. In a landmark oral survey, culture-independent methods detected a broader range of fungi than conventional cultivation alone.³

Mycobiomes participate in nutrient cycling, colonization resistance, and immune education. In the human intestine, fungal cells and products can influence epithelial barriers and the immune system, while host inflammation and diet can in turn reshape the fungal community.¹

Most detected fungi are not established pathogens, and presence does not by itself indicate illness. Nevertheless, shifts in abundance or location may accompany disease, antimicrobial treatment, immune suppression, or disruption of the gut microbiota. Interactions between fungi and bacteria can be cooperative or antagonistic; for example, bacterial metabolites may inhibit fungi, while fungal growth can modify the surrounding chemical environment. On skin, fungal composition varies strongly among anatomical sites, demonstrating that physical habitat is a major ecological factor.⁴

Mycobiomes are shaped by sampling context and by the difference between residence and passage. A swallowed environmental spore may appear in stool without forming a stable intestinal population, while low-abundance residents may be missed by sequencing. Conversely, an abundant signal can reflect extracellular DNA rather than active growth.

The human fungal community also includes organisms that are familiar as harmless commensals but can become opportunistic under altered conditions. Candida albicans, for example, can switch between yeast and filamentous forms and is associated with both ordinary colonization and invasive disease.¹ Mycobiome studies therefore increasingly examine function, spatial location, strain variation, and interactions with bacteria rather than treating species lists as direct measures of health. Comparisons across laboratories remain difficult because collection, sequencing, and classification protocols are not standardized.⁵

Mycobiome

The community of fungi inhabiting a particular environment or host, including its associated genetic material.

Mycobiota

The fungal organisms present in a defined habitat; the term emphasizes the organisms rather than their genes.

ITS

Internal transcribed spacer DNA, a commonly sequenced barcode region for identifying fungi.

Commensal

An organism living with a host without ordinarily causing detectable harm; circumstances can alter that relationship.

Metagenomics

Analysis of genetic material recovered directly from an environmental or host-associated sample.